netFormulary
 Report : A-Z HCD items in Formulary 06/10/2024 00:39:36
[Back]
 
Section Status BlueTeq Name
10.01.03 Formulary BlueTeq Abatacept Orencia®
13.05.03 Formulary BlueTeq Abrocitinib Cibinqo ®
10.01.03 Formulary BlueTeq Adalimumab Biosimilars avaliable
13.05.03 Formulary BlueTeq Adalimumab Biosimilars avaliable
11.08.02 Formulary BlueTeq Aflibercept Eylea®
02.12 Formulary BlueTeq Alirocumab Praluent®
13.05.01 Formulary BlueTeq Alitretinoin Toctino®
10.01.03 Formulary BlueTeq Apremilast 
13.05.03 Formulary BlueTeq Apremilast Otezla®
09.01.04 Formulary BlueTeq Avatrombopag Doptelet®
10.01.03 Formulary BlueTeq Baricitinib Olumiant®
10.01.03 Formulary BlueTeq Bimekizumab Bimzelx®
04.07.04.02 Formulary BlueTeq Botulinum Toxin Type A botox®
13.05.03 Formulary BlueTeq Brodalumab Kyntheum®
11.08.02 Formulary BlueTeq Brolucizumab  Beovu®
10.01.03 Formulary BlueTeq Certolizumab Pegol Cimzia®
13.05.03 Formulary BlueTeq Deucravacitinib SOTYKTU
11.04.01 Formulary BlueTeq Dexamethasone intravitreal implant Ozurdex®
13.05.02 Formulary BlueTeq Dimethyl Fumarate Skilarence®
13.05.03 Formulary BlueTeq Dupilumab Dupixent®
09.01.04 Formulary BlueTeq Eltrombopag Revolade®
04.07.04.02 Formulary BlueTeq Eptinezumab Vyepti®
04.07.04.02 Formulary BlueTeq Erenumab Aimovig®
10.01.03 Formulary BlueTeq Etanercept Biosimilars avaliable
13.05.03 Formulary BlueTeq Etanercept Biosimilars avaliable
02.12 Formulary BlueTeq Evolocumab Repatha®
11.08.02 Formulary BlueTeq Faricimab Vabysmo ®
01.05.03 Formulary BlueTeq Filgotinib 
10.01.03 Formulary BlueTeq Filgotinib  Jyseleca®
11.04.01 Formulary BlueTeq Fluocinolone intravitreal implant Iluvien®
09.01.04 Formulary BlueTeq Fostamatinib  TAVLESSE ®
04.07.04.02 Formulary BlueTeq Fremanezumab Ajovy®
04.07.04.02 Formulary BlueTeq Galcanezumab  Emgality®
01.05.03 Formulary BlueTeq Golimumab 
10.01.03 Formulary BlueTeq Golimumab Simponi®
13.05.03 Formulary BlueTeq Guselkumab Tremfya®
01.05.03 Formulary BlueTeq Infliximab 
10.01.03 Formulary BlueTeq Infliximab Biosimilars avaliable
13.05.03 Formulary BlueTeq Infliximab Biosimilars avaliable
06.01.01.03 Formulary BlueTeq Insulin pumps 
09.01.03 Formulary BlueTeq Iptacopan 
03.07 Formulary BlueTeq Ivacaftor–Tezacaftor–Elexacaftor Kaftrio®
10.01.03 Formulary BlueTeq Ixekizumab 
13.05.02 Formulary BlueTeq Ixekizumab  Taltz®
04.09.01 Formulary BlueTeq Levodopa-Carbidopa- Entacapone Intestinal Gel (LECIG) 
04.09.01 Formulary BlueTeq Levodopa-Carbidopa Intestinal Gel (LCIG) 
03.07 Formulary BlueTeq Lumacaftor–Ivacaftor Orkambi®
03.04.02 Formulary BlueTeq Mepolizumab  
01.05.03 Formulary BlueTeq Mirikizumab 
01.05.03 Formulary BlueTeq Ozanimod 
11.08.02 Formulary BlueTeq Ranibizumab 
03.04.02 Formulary BlueTeq Reslizumab 
01.05.03 Formulary BlueTeq Risankizumab Skyrizi®
10.01.03 Formulary BlueTeq Risankizumab Skyrizi®
13.05.03 Formulary BlueTeq Risankizumab Skyrizi®
09.01.03 Formulary BlueTeq Rituximab 
09.01.04 Formulary BlueTeq Rituximab idiopathic thrombocytopenia in adults
10.01.03 Formulary BlueTeq Rituximab (rheumatology) Biosimilars avaliable
09.01.04 Formulary BlueTeq Romiplostim Nplate®
10.01.03 Formulary BlueTeq Sarilumab Kevzara®
10.01.03 Formulary BlueTeq Secukinumab 
13.05.03 Formulary BlueTeq Secukinumab Cosentyx®
06.05.01 Formulary BlueTeq Somatrogon Ngenla®
03.07 Formulary BlueTeq Tezacaftor–Ivacaftor Symkevi®
13.05.03 Formulary BlueTeq Tildrakizumab Ilumetri®
10.01.03 Formulary BlueTeq Tocilizumab Biosimilars avaliable
01.05.03 Formulary BlueTeq Tofacitinib 
10.01.03 Formulary BlueTeq Tofacitinib Xeljanz®
06.05.02 Formulary BlueTeq Tolvaptan 
01.05.03 Formulary BlueTeq Upadacitinib  Rinvoq ®
10.01.03 Formulary BlueTeq Upadacitinib  Rinvoq ®
13.05.03 Formulary BlueTeq Upadacitinib  Rinvoq ®
10.01.03 Formulary BlueTeq Ustekinumab 
13.05.03 Formulary BlueTeq Ustekinumab Stelara®
09.01.03 Formulary BlueTeq Voxelotor 
Lancashire and South Cumbria